Molecular epidemiology of pESI-carrying Salmonella Infantis in Korea: insights from a one health framework

韩国携带pESI的婴儿沙门氏菌的分子流行病学:来自同一健康框架的启示

阅读:3

Abstract

The emergence and global dissemination of Salmonella Infantis carrying the pESI megaplasmid is a growing public health concern owing to its association with multidrug resistance (MDR), enhanced virulence, and increased environmental adaptability. This study investigated the molecular epidemiology and transmission dynamics of pESI-carrying S. Infantis in the poultry production chain and human clinical cases in Korea. A total of 295 Salmonella isolates were collected from poultry sources (farms, slaughterhouses, and retail meats) in 2023, of which 219 (74.2%) were identified as S. Infantis. Additionally, 22 human-origin S. Infantis isolates collected between 2016 and 2023 were included in this study. Among these 241 S. Infantis isolates, 218 from poultry and one from a human case (collected in 2023) were MDR and carried pESIs, most of which carried blaCTX-M-65 and multiple other resistance genes. Comparative whole-genome sequencing revealed a high degree of genetic similarity between poultry and human pESI-carrying S. Infantis isolates, suggesting probable zoonotic transmission through the chicken supply chain. Structural comparison of complete plasmid sequences further revealed close similarity between Korean and US pESIs, suggesting a potential epidemiological link. This study identified the rapid clonal spread of pESI-carrying S. Infantis in the Korean poultry sector and reported the first identification of pESI-carrying S. Infantis in human clinical isolates in Korea. These findings underscore the urgent need for global surveillance, enhanced biosecurity measures in the poultry industry, and stricter regulations to prevent further dissemination of MDR S. Infantis.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。